Figure 2.
Combination therapy using immunomodulator and anti-tumor necrosis factor agent further extended the median time from Crohn’s disease diagnosis to surgery for patients requiring surgery in years 2005 to 2010 (cohort B). TNF: Tumor necrosis factor; IM: Immunomodulator.